Technology | Breast Density | August 08, 2018

iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis

Breast density assessment software built on artificial intelligence

iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis

August 8, 2018 — iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software solution, PowerLook Density Assessment Version 3.4. The software is compatible with iCAD’s digital breast tomosynthesis (DBT) platform on both GE and Hologic mammography systems, enhancing the company’s comprehensive suite of breast health solutions available in a single platform.

Breast density plays a critical role in both risk assessment and accuracy, as mammography sensitivity is reduced to approximately 48 percent from an average of 98 percent in those women with dense breasts, according to iCAD CEO Ken Ferry. iCAD’s technology rapidly produces consistent breast density results while reducing the risk of reader variability, enabling radiologists to more easily identify women who might benefit from additional screening.

According to a recent study published in the Annals of Internal Medicine, between 40-50 percent of women in the United States are considered to have dense breasts, which can increase tumor aggressiveness, as well as mask the presence of tumors in a mammogram.

iCAD’s PowerLook Density Assessment 3.4 delivers automated, rapid and reproducible assessments of breast density to help identify patients that may experience reduced sensitivity to digital mammography due to dense breast tissue. This technique, based on machine learning, calibrates the patient’s breast density to the appropriate category corresponding to the American College of Radiology's Breast Imaging Reporting and Data System (BI-RADS) reporting system.

“Since implementing PowerLook Density Assessment, our radiologists have been able to provide more consistent breast density results for our patients during screenings. We must consider many aspects of each patient’s case at once, but PowerLook Density Assessment allows us to focus on our primary goal of finding breast cancer. Density matters and we believe the greater accuracy of assessment with iCAD’s PowerLook Density Assessment will result in greater patient satisfaction and improve patient care,” stated Beth Ingram, M.D., radiology, interventional at Reid Health, Indiana.

For more information: www.icadmed.com

Reference

Kerlikowske K., Scott C.G., Mahmoudzadeh A.P., et al. "Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case–Control Study." Annals of Internal Medicine, June 5, 2018. DOI: 10.7326/M17-3008

Related Content

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020
May 29, 2020 — GE Healthcare announced U.S.
Largest case series (n=30) to date yields high frequency (77%) of negative chest CT findings among pediatric patients (10 months-18 years) with COVID-19, while also suggesting common findings in subset of children with positive CT findings

A and B, Unenhanced chest CT scans show minimal GGOs (right lower and left upper lobes) (arrows) and no consolidation. Only two lobes were affected, and CT findings were assigned CT severity score of 2. Image courtesy of American Journal of Roentgenology (AJR)

News | Coronavirus (COVID-19) | May 29, 2020
May 29, 2020 — An investigation published open-access in the ...
AI has the potential to help radiologists improve the efficiency and effectiveness of breast cancer imaging

Getty Images

Feature | Breast Imaging | May 28, 2020 | By January Lopez, M.D.
Headlines around the world the past several months declared that...
United Imaging's uMR OMEGA is designed to provide greater access to magnetic resonance imaging (MRI) with the world’s first ultra-wide 75-cm bore 3T MRI.
News | Magnetic Resonance Imaging (MRI) | May 27, 2020
May 27, 2020 — United Imaging's...
There were several new developments in digital radiography (DR) technology at the 2019 Radiological Society of North America (RSNA) annual meeting. These trends included integration of artificial intelligence (AI) auto detection technologies, more durable glassless detector plates, and technologies to pull more diagnostic data out of X-ray imaging. Some vendors also have redesigned their DR systems to make them more user-friendly and ergonomic. 
Feature | Digital Radiography (DR) | May 26, 2020 | By Dave Fornell
There were several new developments in digital rad...
An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019.

An example of DiA'a automated ejection fraction AI software on the GE vScan POCUS system at RSNA 2019. Photo by Dave Fornell.

News | Ultrasound Imaging | May 26, 2020
May 12, 2020 — DiA Imaging Analysis, a provider of AI based ultrasound analysis solutions, said it received a governm
a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of pol

a Schematic of the system. The entire solid tumour is illuminated from four sides by a four-arm fibre bundle. A cylindrically focused linear array is designed to detect optoacoustic signals from the tumour. In vivo imaging is performed in conical scanning geometry by controlling the rotation and translation stages. The sensing part of the transducer array and the tumour are submerged in water to provide acoustic coupling. b Maximum intensity projections of the optoacoustic reconstruction of a phantom of polyethylene microspheres (diameter, 20 μm) dispersed in agar. The inset shows a zoomed-in view of the region boxed with a yellow dashed line. In addition, the yellow boxes are signal profiles along the xy and z axes across the microsphere centre, as well as the corresponding full width at half-maximum values. c Normalized absorption spectra of Hb, HbO2 and gold nanoparticles (AuNPs). The spectrum for the AuNPs was obtained using a USB4000 spectrometer (Ocean Optics, Dunedin, FL, USA), while the spectra for Hb and HbO2 were taken from http://omlc.org/spectra/haemoglobin/index.html. The vertical dashed lines indicate the five wavelengths used to stimulate the three absorbers: 710, 750, 780, 810 and 850 nm. Optoacoustic signals were filtered into a low-frequency band (red) and high-frequency band (green), which were used to reconstruct separate images.

News | Breast Imaging | May 26, 2020
May 26, 2020 — Breast cancer is the most common cancer in women.
 Recently the versatility of mixed and augmented reality products has come to the forefront of the news, with an Imperial led project at the Imperial College Healthcare NHS Trust. Doctors have been wearing the Microsoft Hololens headsets whilst working on the front lines of the COVID pandemic, to aid them in their care for their patients. IDTechEx have previously researched this market area in its report “Augmented, Mixed and Virtual Reality 2020-2030: Forecasts, Markets and Technologies”, which predicts th

Doctors wearing the Hololens Device. Source: Imperial.ac.uk

News | Artificial Intelligence | May 22, 2020
May 22, 2020 — Recently the versatility of